Application 211732
- Type
- ANDA
- Sponsor
- HETERO LABS LTD III
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OMEPRAZOLE MAGNESIUM | OMEPRAZOLE MAGNESIUM | TABLET, DELAYED RELEASE;ORAL | EQ 20MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211732-001 | OMEPRAZOLE MAGNESIUM | OMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE / ORAL | 2020-03-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211732-001 | OMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE / ORAL | 2020-03-25 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GoodMeds 24HR Acid Reducer Omeprazole 20mg | OMEPRAZOLE 20MG | Cabinet Health P.B.C. | 58c9c8ef-b929-14eb-e063-6294a90a3761 | 2026-08-11 | Warnings | 211732 ANDA211732 |
| Omeprazole | OMEPRAZOLE | Allegiant Health | 3344c589-c4ac-4f2d-8d32-828db4e825a6 | 2025-03-19 | Warnings | 211732 ANDA211732 |
| Omeprazole | OMEPRAZOLE | CHAIN DRUG MARKETING ASSOCIATION, INC. | da09aac6-8fce-448b-98ba-1fc9bce42075 | 2024-04-17 | Warnings | 211732 ANDA211732 |
| Omeprazole | OMEPRAZOLE | A-S Medication Solutions | a52842ac-ac9d-4344-9823-b8b2afb07903 | 2023-12-14 | Warnings | 211732 ANDA211732 |
| Omeprazole | OMEPRAZOLE | Camber Consumer Care Inc | 9c856d3a-e38f-4006-a43a-ec1a9fa0f057 | 2022-11-28 | Warnings | 211732 ANDA211732 69230-318 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69230-318 | Omeprazole | Omeprazole | Camber Consumer Care | ANDA | Current |
| 69230-318 | Omeprazole | Omeprazole | Camber Consumer Care | ANDA | Current |
| 69230-318 | Omeprazole | Omeprazole | Camber Consumer Care Inc | ANDA | Current |
| 69230-318 | Omeprazole | Omeprazole | Camber Consumer Care Inc | ANDA | Current |